Site logo

Deciduous Therapeutics

About the Company

Deciduous Therapeutics is a San Francisco-based biotechnology company focused on enhancing human healthspan by developing therapies that target and eliminate senescent cells—aged or damaged cells that contribute to various age-related diseases. Founded in 2018 by Robin Mansukhani and Dr. Anil Bhushan, the company leverages the body’s innate immune system, particularly Natural Killer T-cells (NKTs), to restore immune surveillance and promote the clearance of these harmful cells .

Print Company

Share